First and second doses of Covishield vaccine provided high level of protection against SARS-CoV-2 infection in highly transmissible settings: results from a prospective cohort of participants residing in congregate facilities in India
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-05-01
|
Series: | BMJ Global Health |
Online Access: | https://gh.bmj.com/content/7/5/e008271.full |
_version_ | 1811255359433605120 |
---|---|
author | Amita Gupta David Peters Richard E Chaisson Tenzin Tsundue Tenzin Namdon Tenzin Tsewang Sonam Topgyal Tashi Dolma Dekyi Lhadon Tsering Choetso Tenzin Woesal Tenzin Yangkyi Zorba Paster Dawa Phunkyi Tsetan Dorji Sadutshang Kunchok Dorjee |
author_facet | Amita Gupta David Peters Richard E Chaisson Tenzin Tsundue Tenzin Namdon Tenzin Tsewang Sonam Topgyal Tashi Dolma Dekyi Lhadon Tsering Choetso Tenzin Woesal Tenzin Yangkyi Zorba Paster Dawa Phunkyi Tsetan Dorji Sadutshang Kunchok Dorjee |
author_sort | Amita Gupta |
collection | DOAJ |
first_indexed | 2024-04-12T17:23:31Z |
format | Article |
id | doaj.art-736c99ed8e9b4a5e9af46341ef357dfe |
institution | Directory Open Access Journal |
issn | 2059-7908 |
language | English |
last_indexed | 2024-04-12T17:23:31Z |
publishDate | 2022-05-01 |
publisher | BMJ Publishing Group |
record_format | Article |
series | BMJ Global Health |
spelling | doaj.art-736c99ed8e9b4a5e9af46341ef357dfe2022-12-22T03:23:24ZengBMJ Publishing GroupBMJ Global Health2059-79082022-05-017510.1136/bmjgh-2021-008271First and second doses of Covishield vaccine provided high level of protection against SARS-CoV-2 infection in highly transmissible settings: results from a prospective cohort of participants residing in congregate facilities in IndiaAmita Gupta0David Peters1Richard E Chaisson2Tenzin Tsundue3Tenzin Namdon4Tenzin Tsewang5Sonam Topgyal6Tashi Dolma7Dekyi Lhadon8Tsering Choetso9Tenzin Woesal10Tenzin Yangkyi11Zorba Paster12Dawa Phunkyi13Tsetan Dorji Sadutshang14Kunchok Dorjee15Department of Medicine, Division of Infectious Diseases, Center for Clinical Global Health Education, Johns Hopkins School of Medicine, Baltimore, Maryland, USA2Centre for Resilience, University of WestminsterCenter for TB Research, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USAPublic Health and Tuberculosis Division, Tibetan Delek Hospital, Dharamsala, Himachal Pradesh, IndiaPublic Health and Tuberculosis Division, Tibetan Delek Hospital, Dharamsala, Himachal Pradesh, IndiaPublic Health and Tuberculosis Division, Tibetan Delek Hospital, Dharamsala, Himachal Pradesh, IndiaPublic Health and Tuberculosis Division, Tibetan Delek Hospital, Dharamsala, Himachal Pradesh, IndiaDepartment of Pathology, Dr. Rajendra Prasad Govt. Medical College, Tanda, Himachal Pradesh, IndiaPublic Health and Tuberculosis Division, Tibetan Delek Hospital, Dharamsala, Himachal Pradesh, IndiaPublic Health and Tuberculosis Division, Tibetan Delek Hospital, Dharamsala, Himachal Pradesh, IndiaPublic Health and Tuberculosis Division, Tibetan Delek Hospital, Dharamsala, Himachal Pradesh, IndiaPublic Health and Tuberculosis Division, Tibetan Delek Hospital, Dharamsala, Himachal Pradesh, IndiaDepartment of Family Medicine, University of Wisconsin, Oregon, Wisconsin, USAPublic Health and Tuberculosis Division, Tibetan Delek Hospital, Dharamsala, Himachal Pradesh, IndiaPublic Health and Tuberculosis Division, Tibetan Delek Hospital, Dharamsala, Himachal Pradesh, IndiaDepartment of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USAhttps://gh.bmj.com/content/7/5/e008271.full |
spellingShingle | Amita Gupta David Peters Richard E Chaisson Tenzin Tsundue Tenzin Namdon Tenzin Tsewang Sonam Topgyal Tashi Dolma Dekyi Lhadon Tsering Choetso Tenzin Woesal Tenzin Yangkyi Zorba Paster Dawa Phunkyi Tsetan Dorji Sadutshang Kunchok Dorjee First and second doses of Covishield vaccine provided high level of protection against SARS-CoV-2 infection in highly transmissible settings: results from a prospective cohort of participants residing in congregate facilities in India BMJ Global Health |
title | First and second doses of Covishield vaccine provided high level of protection against SARS-CoV-2 infection in highly transmissible settings: results from a prospective cohort of participants residing in congregate facilities in India |
title_full | First and second doses of Covishield vaccine provided high level of protection against SARS-CoV-2 infection in highly transmissible settings: results from a prospective cohort of participants residing in congregate facilities in India |
title_fullStr | First and second doses of Covishield vaccine provided high level of protection against SARS-CoV-2 infection in highly transmissible settings: results from a prospective cohort of participants residing in congregate facilities in India |
title_full_unstemmed | First and second doses of Covishield vaccine provided high level of protection against SARS-CoV-2 infection in highly transmissible settings: results from a prospective cohort of participants residing in congregate facilities in India |
title_short | First and second doses of Covishield vaccine provided high level of protection against SARS-CoV-2 infection in highly transmissible settings: results from a prospective cohort of participants residing in congregate facilities in India |
title_sort | first and second doses of covishield vaccine provided high level of protection against sars cov 2 infection in highly transmissible settings results from a prospective cohort of participants residing in congregate facilities in india |
url | https://gh.bmj.com/content/7/5/e008271.full |
work_keys_str_mv | AT amitagupta firstandseconddosesofcovishieldvaccineprovidedhighlevelofprotectionagainstsarscov2infectioninhighlytransmissiblesettingsresultsfromaprospectivecohortofparticipantsresidingincongregatefacilitiesinindia AT davidpeters firstandseconddosesofcovishieldvaccineprovidedhighlevelofprotectionagainstsarscov2infectioninhighlytransmissiblesettingsresultsfromaprospectivecohortofparticipantsresidingincongregatefacilitiesinindia AT richardechaisson firstandseconddosesofcovishieldvaccineprovidedhighlevelofprotectionagainstsarscov2infectioninhighlytransmissiblesettingsresultsfromaprospectivecohortofparticipantsresidingincongregatefacilitiesinindia AT tenzintsundue firstandseconddosesofcovishieldvaccineprovidedhighlevelofprotectionagainstsarscov2infectioninhighlytransmissiblesettingsresultsfromaprospectivecohortofparticipantsresidingincongregatefacilitiesinindia AT tenzinnamdon firstandseconddosesofcovishieldvaccineprovidedhighlevelofprotectionagainstsarscov2infectioninhighlytransmissiblesettingsresultsfromaprospectivecohortofparticipantsresidingincongregatefacilitiesinindia AT tenzintsewang firstandseconddosesofcovishieldvaccineprovidedhighlevelofprotectionagainstsarscov2infectioninhighlytransmissiblesettingsresultsfromaprospectivecohortofparticipantsresidingincongregatefacilitiesinindia AT sonamtopgyal firstandseconddosesofcovishieldvaccineprovidedhighlevelofprotectionagainstsarscov2infectioninhighlytransmissiblesettingsresultsfromaprospectivecohortofparticipantsresidingincongregatefacilitiesinindia AT tashidolma firstandseconddosesofcovishieldvaccineprovidedhighlevelofprotectionagainstsarscov2infectioninhighlytransmissiblesettingsresultsfromaprospectivecohortofparticipantsresidingincongregatefacilitiesinindia AT dekyilhadon firstandseconddosesofcovishieldvaccineprovidedhighlevelofprotectionagainstsarscov2infectioninhighlytransmissiblesettingsresultsfromaprospectivecohortofparticipantsresidingincongregatefacilitiesinindia AT tseringchoetso firstandseconddosesofcovishieldvaccineprovidedhighlevelofprotectionagainstsarscov2infectioninhighlytransmissiblesettingsresultsfromaprospectivecohortofparticipantsresidingincongregatefacilitiesinindia AT tenzinwoesal firstandseconddosesofcovishieldvaccineprovidedhighlevelofprotectionagainstsarscov2infectioninhighlytransmissiblesettingsresultsfromaprospectivecohortofparticipantsresidingincongregatefacilitiesinindia AT tenzinyangkyi firstandseconddosesofcovishieldvaccineprovidedhighlevelofprotectionagainstsarscov2infectioninhighlytransmissiblesettingsresultsfromaprospectivecohortofparticipantsresidingincongregatefacilitiesinindia AT zorbapaster firstandseconddosesofcovishieldvaccineprovidedhighlevelofprotectionagainstsarscov2infectioninhighlytransmissiblesettingsresultsfromaprospectivecohortofparticipantsresidingincongregatefacilitiesinindia AT dawaphunkyi firstandseconddosesofcovishieldvaccineprovidedhighlevelofprotectionagainstsarscov2infectioninhighlytransmissiblesettingsresultsfromaprospectivecohortofparticipantsresidingincongregatefacilitiesinindia AT tsetandorjisadutshang firstandseconddosesofcovishieldvaccineprovidedhighlevelofprotectionagainstsarscov2infectioninhighlytransmissiblesettingsresultsfromaprospectivecohortofparticipantsresidingincongregatefacilitiesinindia AT kunchokdorjee firstandseconddosesofcovishieldvaccineprovidedhighlevelofprotectionagainstsarscov2infectioninhighlytransmissiblesettingsresultsfromaprospectivecohortofparticipantsresidingincongregatefacilitiesinindia |